Viewing Study NCT00081133


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2025-12-31 @ 11:35 PM
Study NCT ID: NCT00081133
Status: COMPLETED
Last Update Posted: 2013-06-05
First Post: 2004-04-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module